Skip to main content

Published locations for Topical Ruxolitinib Effective for AD in Study of Children Ages 2-11 years

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Topical Ruxolitinib Effective for AD in Study of Children Ages 2-11 years

User login

  • Reset your password
  • /content/topical-ruxolitinib-effective-ad-study-children-ages-2-11-years
  • /edermatologynews/article/269700/atopic-dermatitis/topical-ruxolitinib-effective-ad-study-children
  • /familypracticenews/article/269700/atopic-dermatitis/topical-ruxolitinib-effective-ad-study-children
  • /pediatricnews/article/269700/atopic-dermatitis/topical-ruxolitinib-effective-ad-study-children-ages
  • /pediatrics/article/269700/atopic-dermatitis/topical-ruxolitinib-effective-ad-study-children-ages-2
  • /dermatology/article/269700/atopic-dermatitis/topical-ruxolitinib-effective-ad-study-children-ages-2
  • /familymedicine/article/269700/atopic-dermatitis/topical-ruxolitinib-effective-ad-study-children-ages